Guidelines for a genetic risk based approach to advising women with a family history of breast cancer

Journal of Medical Genetics

Volumn 37, Issue 3, 2000, Pages 203-209

  Eccles, D M ^a   Evans, D G R ^b   Mackay, J ^c  

^a PRINCESS ANNE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Genetic risk; Guidelines

Indexed keywords

ARTICLE; BREAST CANCER; FAMILIAL CANCER; GENETIC RISK; MAMMOGRAPHY; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE GENETICS; UNITED KINGDOM;

EID: 0034014737     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.37.3.203     Document Type: Article

References (31)

1. Harper P. Genetics and cancer services. Report of a working group to the Chief Medical Officer, Department of Health, December 1996.
2. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet1991;48:232-42.
3. Eccles DM, Marlow A, Royle GT, Collins A, Morton NE. Genetic epidemiology of early onset breast cancer. J Med Genet 1994;31:944-9.
4. Claus EB, Schildcraut J, Iverson ES, Berry D, Parmigiani G, Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst 1998;90:1824-9.
5. Ford D, Easton D, Bishop DT, Narod SA, Goldgar DE, and the Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet 1994;343:692-5.
6. Parmigiani G, Berry DA, Aguilar O. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-58.
7. Claus EB, Risch N, Thompson WD Autosomal dominant inheritance of early onset breast cancer. Cancer 1994;73:643-51.
8. Andrieu N, Demenais F. Interactions between genetic and reproductive factors in breast cancer risk in a French family sample. Am J Hum Genet 1997;61:678-90.
9. Brunet, JS, Ghadirian P, Rebbeck TR, et al. Effect of smoking on breast cancer in carriers of BRCA1 or BRCA2 genes. J Natl Cancer Inst 1998;10:761-6.
10. Spiegelman D, Colditz GA, Hunter D, Hertzmark, E. Validation of the Gail et al model for predicting individual breast cancer risk, J Natl Cancer Inst 1994;86:600-8.
11. Ottman R, Pike LC, King M, Henderson BE. Practical guide for estimating risk for familial breast cancer. Lancet 1983;ii:556-8.
12. Powles TJ. Status of antiestrogen breast cancer prevention trials. Oncology 1998;12:28-31.
13. Peshkin BN, Lerman C. Genetic counselling for hereditary breast cancer. Lancet 1999;353:2176-7.
14. Evans DGR, Burnell LD, Hopwood P, Howell A. Perception of risk in women with a family history of breast cancer. Br J Cancer 1993;67:612-14.
15. Hopwood P, Keeling F, Long A, Evans G, Howell A. Psychological support and needs of women at genetic risk of breast cancer: some preliminary indicators. Psychooncology 1998;7:402-12.
16. Lloyd S, Watson M, Waites B, et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996;74:482-7.
17. Lalloo F, Cochrane S, Bulman B, et al. An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews. J Med Genet 1998;35:10-12.
18. Fitzgerald MG, MacDonald DJ, Krainer M, et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996;334:143-9.
19. Struewing J, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995;11:198-200.
20. Serova O, Mazoyer S, Puget N, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes. Am J Hum Genet 1997;60:486-95.
21. Eccles DM, Engelfield P, Soulby MA, Campbell IG. BRCA1 mutations in southern England. Br J Cancer 1998;77:2199-203.
22. Couch F, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997;336:1409-15.
23. Simmonds P, Eccles DM, Goddard JG, et al. Is breast conserving treatment appropriate for women with a family history of breast cancer? Proc ASCO 1999;18:A2363.
24. Fletcher SW, Fletcher, RH, Development of clinical guidelines. Lancet 1998;352:1876.
25. Duffy SW, Chen HH, Tabar L, Fagerberg G, Paci E. Sojourn time, sensitivity and positive predictive value of mammography screenng for breast cancer in women aged 40-49. Int J Epidemiol 1996;25:1139-45.
26. Tabar L, Larsson LG, Anderson I, et al. Breast-cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996;68:693-9.
27. Smith RA, Rutledge JH III, Smart CR. Benefit of screening mammography in women aged 40-49; a new meta analysis of randomised controlled trials. Monogr Natl Cancer Inst 1997;22:87-92.
28. Kollias J, Sibbering DM, Blarney RW, et al. Screening women aged less than 50 years with a family history of breast cancer. Eur J Cancer 1998;34:878-83.
29. Lalloo F, Boggis C, Evans DG, Shenton A, Threlfall AG, Howell A. Screening by mammography, women with a family history of breast cancer Eur J Cancer 1998;34:937-40.
30. Moller P, Maehle L, Heimdal K, et al. Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer. Breast 1998;7:55-9.
31. The BASO breast speciality group. The British Association of Surgical Oncology Guidelines for Surgeons in the management of symptomatic breast disease in the UK (1998 revision). Eur J Surg Oncol 1998;24:464-76.